Effective administration of recombinant tissue plasminogen activator (rt-PA) during resuscitation of a post partum patient with massive pulmonary embolism

Zentralblatt fur Gynakologie

Volumn 121, Issue 8, 1999, Pages 396-398

  Cyrkowicz, A ^a   Bajorek, M ^a   Nytko, J ^a   Solarz, W ^a   Werynski W ^a   Orczyk, K ^a  

^a Edward Szczeklik Hospital   (Poland)

Author keywords

Post partum care; Pulmonary embolism; Recombinant tissue plasminogen activator (rt PA)

Indexed keywords

ALTEPLASE; FRESH FROZEN PLASMA; OXYTOCIN; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HEART ARREST; HEART INDEX; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG EMBOLISM; PUERPERIUM; RESUSCITATION; UTERUS BLEEDING;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; PREGNANCY; PUERPERAL DISORDERS; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; RESUSCITATION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032839093     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abildgaard U, Odegaard OR: The clinical significance of inherited antithrombin deficiency. Biomed Progress 3 (1990) 41-44
2. Barbui T, Finazzi G: Clinical trials on antiphospholipid syndrome. What is being done and what is needed? Lupus 3 (1994) 303-307
3. Batard M, Schwarz HP, Griffin JH: Protein S deficiency associated with thromboembolic disease. Thromb Haemostas 54 (1985) 57
4. Bonnar J: Haemostasis and coagulation disorders in pregnancy. In: Haemostasis and thrombosis. Eds.: Bloom AL, Thomas DP. London: Churchill 1987, 570-584
5. Broekmans AW, Van der Linden IK, Veltkamp JJ, Bertina RM: Prevalence of isolated protein C deficiency in patients with venous disease and in the population. Thromb Haemostas 50 (1983) 350
6. Conard J, Horellou MM, Van Dreden P, Samama M.: Pregnancy and congenital deficiency in antithrombin III or protein C. Thromb Haemostas 58 (1987) 39
7. Conley CL, Hartman RC: A hemorrhagic disorders caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31 (1952) 621-622
8. Dahlbäck B: Inherited resistance to activated protein C, a major cause of venous thrombosis is due to a mutation in the factor V gene. Haemostasis 24 (1994) 139-151
9. Demers C, Ginsberg JS: Deep venous thrombosis and pulmonary embolism in pregnancy. Clin Chest Med 13 (1992) 645-656
10. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA: Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med 116 (1992) 754-761
11. Engelmann L, Ruckhaberle KF, Engelmann B, Sheel H, Vogtmann C, Deckert F: Gestose. Thrombophilie und Lungenembolie bei einer Primipara mit Zwillingschwangerschaft. Z Gesamte Inn Med 48 (1993) 190-196
12. Goldhaber SZ, Kassler CM, Hejt J, Markis JE, Sharma GV, Dawley DL, Nagel JS, Meyerovitz MF, Kim DS, Vaughan DE: Randomized controlled trial of rt-PA vs. urokinase in the treatment of acute pulmonary embolism. Lancet II (1988) 293-298
13. Goldhaber SZ, Vaughan DE, Markis JE, Selwym AP, Meyerowitz MF, Loscalzo J, Kim DS, Kessler CM, Dawley DL, Sharma GV: Acute pulmonary embolism treated with tissue plasminogen activator. Lancet II (1986) 886-889
14. Heidenreich W: Klinik der Fruchtwasserembolie. Zentralbl Gynakol 115 (1993) 233-237
15. Kirkegaard A: Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Gynecol Scand 62 (1983) 239-243
16. Leiberman IR, Fraser D, Mazor M, Glazerman M: Maternal mortality in southern Israel. Arch Gynecol Obstet 252 (1993) 203-207
17. Lijnen HR, CoNen D: Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding and thrombosis. Fibrinolysis 3 (1989) 67-77
18. Malm J, Laurell M, Nilsson M, Dahlbäck B: Protein S and fibrinolytic system in patients with a history of thrombosis. Thromb Haemostas 58 (1987) 229
19. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87 (1990) 4120-4124
20. Onoyama Y, Minamitani M, Takeuchi H, Sakai S, Eguchi H: Use of recombinant tissue-type plasminogen activator to treat massive pulmonary embolism after cesarean section: a case report. J Obstet Gynaecol Res (CLG) 22 (1996) 201-208
21. Poole J: Pulmonary embolism. NAACOGS Clin Issu Perinat Women's Health Nurs 3 (1992) 461-468
22. Rabl H, Frühwirth H: Die klinische Bedeutung von Protein C und -S-Mangelzuständen für das chirurgische Patientenkollektiv. Langenbecks Arch Chir 377 (1992) 75-80
23. Sisson MC: Amniotic fluid embolism. NAACOGS Clin Issu Perinat Women's Health Nurs 3 (1992) 469-474
24. Wright SD, Tuddenham EGD: Myeloproliferative and metabolic causes. In: Bailliere's clinical haematology; Thrombophilia. Ed.: Meade TW London: Bailliere Tindall 1994, 591-635
25. Van Heusden AM, Merkus HM, Dullemond-Westland AC: Pregnancy and protein C deficiency. Eur J Obstet Gynecol Reprod Biol 45 (1992) 207-210
26. Von Felten A: Venöse Thromboembolieprophylaxe mit Heparin bei Risikopatientinnen während der Schwangerschaft: Monitorisierung mittels Messung der Thrombin-Antithrombin-III-Komplexe. Ther Umsch 49 (1992) 837-842